Evidence map›Paper›PMID 30061721›Full record

ArticleScientific reports2018

Liver clear cell foci and viral infection are associated with non-cirrhotic, non-fibrolamellar hepatocellular carcinoma in young patients from South America.

Luis Cano, Juan Pablo Cerapio, Eloy Ruiz, Agnès Marchio, Bruno Turlin, Sandro Casavilca, Luis Taxa, Guillaume Marti, Eric Deharo, Pascal Pineau and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Luis CanoUniversité de Rennes 1, INSERM, CNRS, U 1241 NUMECAN, Rennes, France.ORCID 0000-0002-3417-8750
Juan Pablo CerapioSorbonne Universités, UPMC Univ Paris 06, Institut Pasteur, Unité Organisation Nucléaire et Oncogenèse, Paris, France.ORCID 0000-0002-3032-3180
Eloy RuizInstituto Nacional de Enfermedades Neoplásicas, Departamento de Cirugía en Abdomen, Lima, Peru.
Agnès MarchioInstitut Pasteur, Unité Organisation Nucléaire et Oncogenèse, INSERM, U 993, Paris, France.
Bruno TurlinUniversité de Rennes 1, INSERM, CNRS, U 1241 NUMECAN, Rennes, France.
Sandro CasavilcaInstituto Nacional de Enfermedades Neoplásicas, Departamento de Patología, Lima, Peru.ORCID 0000-0001-8406-739X
Luis TaxaInstituto Nacional de Enfermedades Neoplásicas, Departamento de Patología, Lima, Peru.
Guillaume MartiUniversité de Toulouse, IRD, UPS, UMR 152 PHARMADEV, Toulouse, France.ORCID 0000-0002-6321-9005
Eric DeharoUniversité de Toulouse, IRD, UPS, UMR 152 PHARMADEV, Toulouse, France.
Pascal PineauInstitut Pasteur, Unité Organisation Nucléaire et Oncogenèse, INSERM, U 993, Paris, France.
Stéphane BertaniUniversité de Toulouse, IRD, UPS, UMR 152 PHARMADEV, Toulouse, France. stephane.bertani@ird.fr.ORCID 0000-0002-0398-9745
Instituto Nacional de Enfermedades Neoplásicas · PEUniversité Toulouse III - Paul Sabatier · FRCentre National de la Recherche Scientifique · FRInserm · FRInstitut Pasteur · FR

Funding

Ligue Contre le Cancer Labelled team
6 · The paper itself

Abstract

We previously described a divergent clinical and molecular presentation of hepatocellular carcinoma (HCC) in Peru. The present study aimed to further characterize the tissue features associated with this singular nosological form of HCC in order to gain insight into the natural history of the disease. We performed an exploratory analysis of the histology of both tumor and non-tumor liver (NTL) tissues from 50 Peruvian HCC patients, and compared with that of 75 individuals with non-HCC liver tumor or benign liver lesions as a baseline for NTL features. We complemented this approach with a transcriptome analysis in a subset of NTL tissue samples and also performed an ultra-sensitive hepatitis B virus (HBV) detection in liver tissues of the patients. Overall, results highlighted the low rate of liver parenchymal alterations in a young patient cohort (median age: 40 years old), despite a strong prevalence of underlying HBV infection (c. 67%). Withal, liver clear cell foci of cellular alteration were genuinely associated with HCC and appended to some changes in immune and G protein-coupled receptor gene expression ontologies. Our findings confirm the occurrence of a particular setting of HCC in South America, a region where the pathophysiology of liver cancer remains largely unexplored.

Indexed as

AdolescentAdultAgedAged, 80 and overalpha-FetoproteinsCarcinoma, HepatocellularChildCohort StudiesDNA, ViralFatty LiverFemaleFibrosisHepatitis B, ChronicHepatitis B virusHepatocytesHumansAFP protein, humanalpha-FetoproteinsDNA, Viral

Identifiers

PMID30061721
PMCPMC6065419
OpenAlexW2810366022

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.